White & Case advises Servier on financing for Edgewise Therapeutics acquisition and revolving credit facility refinancing

Global law firm White & Case LLP has advised the independent international pharmaceutical group Servier on the financing of the acquisition of Edgewise Therapeutics, a biopharmaceutical company specializing in the development of innovative therapies for severe muscular disorders, for an amount of US$1.55 billion, and on the refinancing of its existing revolving credit facility.

The financing of the acquisition included a €1.55 billion facilities agreement comprising a term loan facility and a bridge facility. In parallel, a €700 million revolving credit facility (RCF) was arranged.

The White & Case team in Paris which advised on the transaction was led by partner Neeloferr Roy and included associates Martin Poirier, Yacine Arhmir and Chloé Amado.

Press contact
For more information please speak to your local media contact.